BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 10410669)

  • 1. [Trends in comprehensive treatment for gynecologic malignancies].
    Yakushiji M; Fujiyoshi K; Komai K; Imamura K
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():145-56. PubMed ID: 10410669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
    Curtin JP; Shapiro F
    Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment concepts for gynecologic pelvic malignancies: neoadjuvant therapies.
    Restivo A; Gordinier M; Granai CO
    Surg Oncol Clin N Am; 2005 Apr; 14(2):239-47. PubMed ID: 15817237
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of gynecologic cancer in elderly patients].
    Ochiai K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):990-4. PubMed ID: 9644312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
    Sugiyama T; Yoshizaki A; Hatayama S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
    Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
    Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):431-8. PubMed ID: 9063480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Minimally invasive treatment of gynecologic cancers].
    Ichikawa Y; Yoshikawa H
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1090-3. PubMed ID: 11525023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in intraarterial chemotherapy in gynecologic malignancy].
    Shimizu Y
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):189-96. PubMed ID: 11865623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of gynecologic malignomas].
    Janisch H
    Gynakol Rundsch; 1982; 22(2):145-50. PubMed ID: 7106626
    [No Abstract]   [Full Text] [Related]  

  • 17. [Latest information in the diagnoses of ovarian carcinoma].
    Isonishi S
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1351-7. PubMed ID: 12214460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in the surgical management of ovarian cancer].
    Faridi A; Schröder W; Rath W
    Zentralbl Gynakol; 1998; 120(1):3-16. PubMed ID: 9499545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ; Rotmensch J; Waggoner SE; Yamada D; Langhauser C; Fleming GF
    Gynecol Oncol; 2001 Aug; 82(2):333-7. PubMed ID: 11531289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.